Integrin-α5β1 is not required for mural cell functions during development of blood vessels but is required for lymphatic-blood vessel separation and lymphovenous valve formation

Developmental Biology

Volumn 392, Issue 2, 2014, Pages 381-392

  Turner, Christopher J ^a   Badu Nkansah, Kwabena ^a   Crowley, Denise ^a   van der Flier, Arjan ^a   Hynes, Richard O ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Integrin; Lymphatic vessels; Mural cells; PDGFR

Indexed keywords

VERY LATE ACTIVATION ANTIGEN 5;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; BLEEDING; BLOOD VESSEL PARAMETERS; CAPILLARY; CELL FUNCTION; CONTROLLED STUDY; EDEMA; EMBRYO; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; FEMALE; GENE; GENE DELETION; GENE EXPRESSION; LTGA5 GENE; LYMPH VESSEL; LYMPHATIC BLOOD VESSEL SEPARATION; LYMPHOVENOUS VALVE FORMATION; MOUSE; NONHUMAN; PDGFRB GENE; PERICYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; SMOOTH MUSCLE FIBER; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

MUS; MUS MUSCULUS;

INTEGRIN; LYMPHATIC VESSELS; MURAL CELLS; PDGFRΒ;

ANIMALS; BLOOD VESSELS; FLUORESCENT ANTIBODY TECHNIQUE; INTEGRASES; INTEGRIN ALPHA6BETA1; LYMPHATIC VESSELS; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; VENOUS VALVES; X-RAY MICROTOMOGRAPHY;

EID: 84904397899     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2014.05.006     Document Type: Article

References (74)

1. Abraham S., Kogata N., Fassler R., Adams R.H. Integrin beta1 subunit controls mural cell adhesion, spreading, and blood vessel wall stability. Circ. Res. 2008, 102:562-570.
2. Abtahian F., Guerriero A., Sebzda E., Lu M.M., Zhou R., Mocsai A., Myers E.E., Huang B., Jackson D.G., Ferrari V.A., Tybulewicz V., Lowell C.A., Lepore J.J., Koretzky G.A., Kahn M.L. Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science 2003, 299:247-251.
3. Alitalo K. The lymphatic vasculature in disease. Nat. Med. 2011, 17:1371-1380.
4. Astrof S., Hynes R.O. Fibronectins in vascular morphogenesis. Angiogenesis 2009, 12:165-175.
5. Avraamides C.J., Garmy-Susini B., Varner J.A. Integrins in angiogenesis and lymphangiogenesis. Nat. Rev. Cancer 2008, 8:604-617.
6. Bader B.L., Rayburn H., Crowley D., Hynes R.O. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins. Cell 1998, 95:507-519.
7. Barillari G., Albonici L., Incerpi S., Bogetto L., Pistritto G., Volpi A., Ensoli B., Manzari V. Inflammatory cytokines stimulate vascular smooth muscle cells locomotion and growth by enhancing alpha5beta1 integrin expression and function. Atherosclerosis 2001, 154:377-385.
8. Bazigou E., Makinen T. Flow control in our vessels: vascular valves make sure there is no way back. Cell. Mol. Life Sci. 2013, 70:1055-1066.
9. Bazigou E., Xie S., Chen C., Weston A., Miura N., Sorokin L., Adams R., Muro A.F., Sheppard D., Makinen T. Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev. Cell 2009, 17:175-186.
10. Benedito R., Roca C., Sorensen I., Adams S., Gossler A., Fruttiger M., Adams R.H. The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 2009, 137:1124-1135.
11. Bertozzi C.C., Hess P.R., Kahn M.L. Platelets: covert regulators of lymphatic development. Arterioscler Thromb Vasc. Biol. 2010, 30:2368-2371.
12. Cao R., Bjorndahl M.A., Religa P., Clasper S., Garvin S., Galter D., Meister B., Ikomi F., Tritsaris K., Dissing S., Ohhashi T., Jackson D.G., Cao Y. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 2004, 6:333-345.
13. Chen J., Alexander J.S., Orr A.W. Integrins and their extracellular matrix ligands in lymphangiogenesis and lymph node metastasis. Int. J. Cell Biol. 2012, 2012:853703.
14. Chervenak F.A., Isaacson G., Blakemore K.J., Breg W.R., Hobbins J.C., Berkowitz R.L., Tortora M., Mayden K., Mahoney M.J. Fetal cystic hygroma. Cause and natural history. N. Engl. J. Med. 1983, 309:822-825.
15. Courtoy P.J., Boyles J. Fibronectin in the microvasculature: localization in the pericyte-endothelial interstitium. J. Ultrastruct. Res. 1983, 83:258-273.
16. D'Amico G., Jones D.T., Nye E., Sapienza K., Ramjuan A.R., Reynolds L.E., Robinson S.D., Kostourou V., Martinez D., Aubyn D., Grose R., Thomas G.J., Spencer-Dene B., Zicha D., Davies D., Tybulewicz V., Hodivala-Dilke K.M. Regulation of lymphatic-blood vessel separation by endothelial Rac1. Development 2009, 136:4043-4053.
17. Davenpeck K.L., Marcinkiewicz C., Wang D., Niculescu R., Shi Y., Martin J.L., Zalewski A. Regional differences in integrin expression: role of alpha(5)beta(1) in regulating smooth muscle cell functions. Circ. Res. 2001, 88:352-358.
18. Dietrich T., Onderka J., Bock F., Kruse F.E., Vossmeyer D., Stragies R., Zahn G., Cursiefen C. Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade. Am. J. Pathol. 2007, 171:361-372.
19. Flintoff-Dye N.L., Welser J., Rooney J., Scowen P., Tamowski S., Hatton W., Burkin D.J. Role for the alpha7beta1 integrin in vascular development and integrity. Dev. Dyn. 2005, 234:11-21.
20. Földi M., Strössenreuther R.H.K. Foundations of manual lymph drainage 2005, ebrary Inc, Mosby, St. Louis. 3rd ed.
21. Foo S.S., Turner C.J., Adams S., Compagni A., Aubyn D., Kogata N., Lindblom P., Shani M., Zicha D., Adams R.H. Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell 2006, 124:161-173.
22. Francis S.E., Goh K.L., Hodivala-Dilke K., Bader B.L., Stark M., Davidson D., Hynes R.O. Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler Thromb. Vasc. Biol. 2002, 22:927-933.
23. Francois M., Short K., Secker G.A., Combes A., Schwarz Q., Davidson T.L., Smyth I., Hong Y.K., Harvey N.L., Koopman P. Segmental territories along the cardinal veins generate lymph sacs via a ballooning mechanism during embryonic lymphangiogenesis in mice. Dev. Biol. 2012, 364:89-98.
24. Garmy-Susini B., Avraamides C.J., Schmid M.C., Foubert P., Ellies L.G., Barnes L., Feral C., Papayannopoulou T., Lowy A., Blair S.L., Cheresh D., Ginsberg M., Varner J.A. Integrin alpha4beta1 signalling is required for lymphangiogenesis and tumor metastasis. Cancer Res. 2010, 70:3042-3051.
25. Garmy-Susini B., Jin H., Zhu Y., Sung R.J., Hwang R., Varner J. Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation. J. Clin. Invest. 2005, 115:1542-1551.
26. George E.L., Baldwin H.S., Hynes R.O. Fibronectins are essential for heart and blood vessel morphogenesis but are dispensable for initial specification of precursor cells. Blood 1997, 90:3073-3081.
27. George E.L., Georges-Labouesse E.N., Patel-King R.S., Rayburn H., Hynes R.O. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 1993, 119:1079-1091.
28. Goodman S.L., Picard M. Integrins as therapeutic targets. Trends Pharmacol. Sci. 2012, 33:405-412.
29. Grazioli A., Alves C.S., Konstantopoulos K., Yang J.T. Defective blood vessel development and pericyte/pvSMC distribution in alpha 4 integrin-deficient mouse embryos. Dev. Biol. 2006, 293:165-177.
30. Hagerling R., Pollmann C., Andreas M., Schmidt C., Nurmi H., Adams R.H., Alitalo K., Andresen V., Schulte-Merker S., Kiefer F. A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy. EMBO J. 2013, 32:629-644.
31. Haiko P. VEGF-C/VEGFR-3 and PDGF-B/PDGFR-beta pathways in embryonic lymphangiogenesis, Haartman Institute and Biomedicum Helsinki 2008, University of Helsinki.
32. Harada K., Yamazaki T., Iwata C., Yoshimatsu Y., Sase H., Mishima K., Morishita Y., Hirashima M., Oike Y., Suda T., Miura N., Watabe T., Miyazono K. Identification of targets of Prox1 during in vitro vascular differentiation from embryonic stem cells: functional roles of HoxD8 in lymphangiogenesis. J. Cell Sci. 2009, 122:3923-3930.
33. Hedin U., Thyberg J. Plasma fibronectin promotes modulation of arterial smooth-muscle cells from contractile to synthetic phenotype. Differentiation 1987, 33:239-246.
34. Heldin C.H., Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 1999, 79:1283-1316.
35. Hellstrom M., Kalen M., Lindahl P., Abramsson A., Betsholtz C. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 1999, 126:3047-3055.
36. Hirschi K.K., Rohovsky S.A., Beck L.H., Smith S.R., D'Amore P.A. Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ. Res. 1999, 84:298-305.
37. Hodivala-Dilke K.M., McHugh K.P., Tsakiris D.A., Rayburn H., Crowley D., Ullman-Cullere M., Ross F.P., Coller B.S., Teitelbaum S., Hynes R.O. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J. Clin Invest. 1999, 103:229-238.
38. Hollier B.G., Tinnirello A.A., Werden S.J., Evans K.W., Taube J.H., Sarkar T.R., Sphyris N., Shariati M., Kumar S.V., Battula V.L., Herschkowitz J.I., Guerra R., Chang J.T., Miura N., Rosen J.M., Mani S.A. FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer. Cancer Res. 2013, 73:1981-1992.
39. Huang X., Griffiths M., Wu J., Farese R.V., Sheppard D. Normal development, wound healing, and adenovirus susceptibility in beta5-deficient mice. Mol. Cell Biol. 2000, 20:755-759.
40. Huang X.Z., Wu J.F., Ferrando R., Lee J.H., Wang Y.L., Farese R.V., Sheppard D. Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1. Mol. Cell Biol. 2000, 20:5208-5215.
41. Hynes R.O. Cell-matrix adhesion in vascular development. J. Thromb. Haemost. 2007, 5(Suppl 1):S32-S40.
42. Kale S., Hanai J., Chan B., Karihaloo A., Grotendorst G., Cantley L., Sukhatme V.P. Microarray analysis of in vitro pericyte differentiation reveals an angiogenic program of gene expression. FASEB J. 2005, 19:270-271.
43. Kim S., Bell K., Mousa S.A., Varner J.A. Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am. J. Pathol. 2000, 156:1345-1362.
44. Kisanuki Y.Y., Hammer R.E., Miyazaki J., Williams S.C., Richardson J.A., Yanagisawa M. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev. Biol. 2001, 230:230-242.
45. Kogata N., Tribe R.M., Fassler R., Way M., Adams R.H. Integrin-linked kinase controls vascular wall formation by negatively regulating Rho/ROCK-mediated vascular smooth muscle cell contraction. Genes. Dev. 2009, 23:2278-2283.
46. Lacy-Hulbert A., Smith A.M., Tissire H., Barry M., Crowley D., Bronson R.T., Roes J.T., Savill J.S., Hynes R.O. Ulcerative colitis and autoimmunity induced by loss of myeloid alphav integrins. Proc. Natl. Acad. Sci. USA 2007, 104:15823-15828.
47. Leveen P., Pekny M., Gebre-Medhin S., Swolin B., Larsson E., Betsholtz C. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes. Dev. 1994, 8:1875-1887.
48. Lindahl P., Johansson B.R., Leveen P., Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 1997, 277:242-245.
49. Makinen T., Adams R.H., Bailey J., Lu Q., Ziemiecki A., Alitalo K., Klein R., Wilkinson G.A. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes. Dev. 2005, 19:397-410.
50. Moiseeva E.P. Adhesion receptors of vascular smooth muscle cells and their functions. Cardiovasc. Res. 2001, 52:372-386.
51. Muether P.S., Dell S., Kociok N., Zahn G., Stragies R., Vossmeyer D., Joussen A.M. The role of integrin alpha5beta1 in the regulation of corneal neovascularization. Exp. Eye Res. 2007, 85:356-365.
52. Muzumdar M.D., Tasic B., Miyamichi K., Li L., Luo L. A global double-fluorescent Cre reporter mouse. Genesis 2007, 45:593-605.
53. Okazaki T., Ni A., Ayeni O.A., Baluk P., Yao L.C., Vossmeyer D., Zischinsky G., Zahn G., Knolle J., Christner C., McDonald D.M. alpha5beta1 Integrin blockade inhibits lymphangiogenesis in airway inflammation. Am. J. Pathol. 2009, 174:2378-2387.
54. Petrova T.V., Karpanen T., Norrmen C., Mellor R., Tamakoshi T., Finegold D., Ferrell R., Kerjaschki D., Mortimer P., Yla-Herttuala S., Miura N., Alitalo K. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat. Med. 2004, 10:974-981.
55. Reynolds L.E., Wyder L., Lively J.C., Taverna D., Robinson S.D., Huang X., Sheppard D., Hynes R.O., Hodivala-Dilke K.M. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat. Med. 2002, 8:27-34.
56. Soriano P. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes. Dev. 1994, 8:1888-1896.
57. Srinivasan R.S., Dillard M.E., Lagutin O.V., Lin F.J., Tsai S., Tsai M.J., Samokhvalov I.M., Oliver G. Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. Genes Dev. 2007, 21:2422-2432.
58. Srinivasan R.S., Oliver G. Prox1 dosage controls the number of lymphatic endothelial cell progenitors and the formation of the lymphovenous valves. Genes Dev. 2011, 25:2187-2197.
59. Tammela T., Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise. Cell 2010, 140:460-476.
60. Tiedt R., Schomber T., Hao-Shen H., Skoda R.C. Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo. Blood 2007, 109:1503-1506.
61. Turlo K.A., Noel O.D., Vora R., LaRussa M., Fassler R., Hall-Glenn F., Iruela-Arispe M.L. An essential requirement for beta1 integrin in the assembly of extracellular matrix proteins within the vascular wall. Dev. Biol. 2012, 365:23-35.
62. Uhrin P., Zaujec J., Breuss J.M., Olcaydu D., Chrenek P., Stockinger H., Fuertbauer E., Moser M., Haiko P., Fassler R., Alitalo K., Binder B.R., Kerjaschki D. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood 2010, 115:3997-4005.
63. Umeda N., Kachi S., Akiyama H., Zahn G., Vossmeyer D., Stragies R., Campochiaro P.A. Suppression and regression of choroidal neovascularization by systemic administration of an alpha5beta1 integrin antagonist. Mol. Pharmacol. 2006, 69:1820-1828.
64. van der Flier A., Badu-Nkansah K., Whittaker C.A., Crowley D., Bronson R.T., Lacy-Hulbert A., Hynes R.O. Endothelial alpha5 and alphav integrins cooperate in remodeling of the vasculature during development. Development 2010, 137:2439-2449.
65. van der Putte S.C. The development of the lymphatic system in man. Adv. Anat. Embryol. Cell Biol. 1975, 51:3-60.
66. Veevers-Lowe J., Ball S.G., Shuttleworth A., Kielty C.M. Mesenchymal stem cell migration is regulated by fibronectin through alpha5beta1-integrin-mediated activation of PDGFR-beta and potentiation of growth factor signals. J. Cell Sci. 2011, 124:1288-1300.
67. Wierzbicka-Patynowski I., Schwarzbauer J.E. The ins and outs of fibronectin matrix assembly. J. Cell Sci. 2003, 116:3269-3276.
68. Wigle J.T., Harvey N., Detmar M., Lagutina I., Grosveld G., Gunn M.D., Jackson D.G., Oliver G. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 2002, 21:1505-1513.
69. Wigle J.T., Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 1999, 98:769-778.
70. Xie L., Duncan M.B., Pahler J., Sugimoto H., Martino M., Lively J., Mundel T., Soubasakos M., Rubin K., Takeda T., Inoue M., Lawler J., Hynes R.O., Hanahan D., Kalluri R. Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner. Proc. Natl. Acad. Sci. USA 2011, 108:9939-9944.
71. Yang J.T., Rayburn H., Hynes R.O. Embryonic mesodermal defects in alpha 5 integrin-deficient mice. Development 1993, 119:1093-1105.
72. Yang M., Khachigian L.M., Hicks C., Chesterman C.N., Chong B.H. Identification of PDGF receptors on human megakaryocytes and megakaryocytic cell lines. Thromb. Haemost. 1997, 78:892-896.
73. Yang Y., Garcia-Verdugo J.M., Soriano-Navarro M., Srinivasan R.S., Scallan J.P., Singh M.K., Epstein J.A., Oliver G. Lymphatic endothelial progenitors bud from the cardinal vein and intersomitic vessels in mammalian embryos. Blood 2012, 120:2340-2348.
74. Zhang X., Groopman J.E., Wang J.F. Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin alpha5beta1. J. Cell Physiol. 2005, 202:205-214.